Tag
Emcure Pharmaceuticals Limited
2 articles
Emcure Receives ₹577 Crore Income Tax Penalty
Emcure Pharmaceuticals discloses regulatory orders from the Income-tax Department imposing an aggregate penalty of ₹57.74 crore.
The penalty covers financial years 2014-15 to 2020-21 (assessment years
Emcure FY26 Revenue Up 16.6% with 33.1% PAT Growth
Emcure reported FY26 revenue of ₹92,035 Mn, up 16.6% YoY, with PAT growing 33.1% to ₹9,413 Mn and margins expanding 120 bps.
The company's India business grew 10% to ₹40,270 Mn with 60%+ chronic mix,